Menu
No results found.
USPH
U.S. Physical Therapy, Inc. – NYSE
Weekly Share Price & Valuation Overview
Market Overview
Open
85.5000
Close
85.7800
High
86.2500
Low
84.0000
Trend
0.30991
U.S. Physical Therapy, Inc.
United States
• NYSE - New York Stock Exchange
• USPH
• Currency: USD
U.S. Physical Therapy, Inc. operates and manages outpatient physical therapy clinics. The company operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
Key strengths
- Revenue growth ≥10% indicates solid top-line momentum.
- Earnings growth ≥10% supports improving profitability trajectory.
- Quick ratio ≥1.0 indicates obligations can be met without inventory.
Scale & Structure
Core size and share structure. TTM values unless noted. “Estimated” where reconciled from per-share × shares.
- Market Cap Total equity value of the company (share price × shares outstanding).
- USD 1.30B
- Enterprise Value Operating value: market cap + total debt − cash.
- USD 1.84B
- Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- USD 722.20M
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- USD 159.27M
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- USD 96.66M
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- USD 47.75
- EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
- 2.29
- Dividend Yield Annual dividend ÷ share price. Reconciled using dividend per share when available.
- 2.10%
- Shares Outstanding
- 15.20M
- Float Shares
- 14.89M
- Implied Shares Outstanding
- 15.20M
Profitability & Efficiency
TTM basis. “Reconciled” = numerator ÷ TTM revenue. Margins reflect latest TTM calculations.
- Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
12.40%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
13.38%
- Gross Margin (TTM) Reconciled Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
22.05%
- Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
-
5.28%
- ROA Return on assets: net income ÷ total assets.
-
4.24%
- ROE Return on equity: net income ÷ shareholder equity.
-
7.45%
Growth
Growth rates are YoY unless labeled QoQ.
- Revenue Growth Strong Year-over-year revenue growth.
-
18.10%
- Earnings Growth (YoY) Strong Year-over-year earnings growth.
-
24.10%
- Earnings Growth (QoQ) Quarter-over-quarter earnings growth.
-
65.10%
Liquidity & Solvency
Balance-sheet health. Debt metrics shown as latest ratios; D/E is a ratio (not %).
- Quick Ratio Adequate Liquid current assets ÷ current liabilities (ex-inventory).
- 1.08
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 0.40
- Total Cash Cash and equivalents.
- USD 35.41M
- Total Debt Short + long-term interest-bearing debt.
- USD 305.40M
- Net Debt Total debt − cash (negative = net cash).
- USD 269.99M
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- 3.16
Cash Flow
Shown only when internally consistent; margins are TTM.
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- USD 71.72M
- Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
- USD 48.72M
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
9.93%
- FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-
6.75%
- Cash Conversion (OpCF/EBITDA)
- 0.74
Sharemaestro House View
Confidence: 2
Sharemaestro internal conviction (0–3, higher is better).
Risk: 1
Sharemaestro internal risk profile (0–3, higher is safer).
Operational: 2
Operational quality/consistency (0–3, higher is better).
Composite Score: 2
Overall internal composite (0–3, higher is better).
Suggested Allocation: 3.33%
Indicative portfolio weighting suggestion based on house view.
Structural Insights
(experimental)
Ownership & Liquidity
Free Float
Proportion of shares available for public trading.
97.9%
Insiders
Shares held by company insiders (officers, directors).
2.0%
Institutions
Shares held by institutions (funds, pensions).
1.1%
Capital Structure
Potential Dilution
Increase in share count if options/convertibles exercise.
None detected
Net Debt
Total debt − cash (negative = net cash).
USD 269.99M
37.4% of revenue
Net debt relative to revenue — debt load vs business scale.
Resilience Score
0–100 composite of liquidity, leverage and cash conversion; higher is better. If inputs are unavailable, we estimate using proxies (Net debt vs revenue, Cash-to-Debt). It is a guide, not a rating.
37
Methodology Notes
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
As of: 2025-08-18 03:52
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.
AI generated insights not available yet. Sign in to generate the snapshot.